The NCE-1 opportunity refers to the chance for generic drug manufacturers to challenge patents and seek market entry just before the expiration of a New Chemical Entity's (NCE) exclusivity. This typically occurs one year before the NCE exclusivity ends, allowing generic companies to prepare and potentially launch their products as soon as the exclusivity expires.